Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?

143Citations
Citations of this article
265Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The objective of this article is to compare and contrast the international expectations associated with the model-independent similarity factor approach to comparing dissolution profiles. This comparison highlights globally divergent regulatory requirements to meet local dissolution similarity requirements. In effect, experiments customized to meet the current international regulatory expectations for dissolution and drug release unnecessarily increase manufacturing costs, hinder science and risk-based approaches, increase collective regulatory burden, reduce continuous improvement and innovation, and potentially delay patient access to urgently needed medication. Comparative assessment of regulatory differences in applying dissolution to demonstrate product similarity is crucial to reduce non-scientifically justified experiments and foster collaborative harmonization among global regulatory health authorities and the pharmaceutical industry.

Cite

CITATION STYLE

APA

Diaz, D. A., Colgan, S. T., Langer, C. S., Bandi, N. T., Likar, M. D., & Van Alstine, L. (2016). Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations? AAPS Journal, 18(1), 15–22. https://doi.org/10.1208/s12248-015-9830-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free